What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Cell biology, TSC1, TSC2, Genetics and Tuberous sclerosis are his primary areas of study.
His work is dedicated to discovering how Cell biology, Molecular biology are connected with Cell growth and other disciplines.
His TSC1 study combines topics in areas such as mTORC1, Heterozygote advantage, Neuroscience and Sirolimus.
As a member of one scientific family, David J. Kwiatkowski mostly works in the field of TSC2, focusing on Cancer research and, on occasion, Protein kinase B, CDKN2A, Chromophobe cell, Carcinoma and Germline mutation.
His Tuberous sclerosis research also works with subjects such as
- Tuberous sclerosis protein, which have a strong connection to Genotype,
- Hamartoma together with Endocrinology.
His research investigates the connection between Gene and topics such as Adenocarcinoma that intersect with issues in KRAS.
His most cited work include:
- Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
- Comprehensive genomic characterization of squamous cell lung cancers (2590 citations)
- Comprehensive molecular characterization of urothelial bladder carcinoma (1756 citations)
What are the main themes of his work throughout his whole career to date?
David J. Kwiatkowski focuses on Cancer research, Tuberous sclerosis, Genetics, TSC1 and Internal medicine.
His work focuses on many connections between Cancer research and other disciplines, such as PI3K/AKT/mTOR pathway, that overlap with his field of interest in Sirolimus and Protein kinase B.
David J. Kwiatkowski works mostly in the field of TSC1, limiting it down to topics relating to TSC2 and, in certain cases, Germline mutation and Tumor suppressor gene, as a part of the same area of interest.
The various areas that David J. Kwiatkowski examines in his Internal medicine study include Endocrinology and Oncology.
His work in Gene addresses subjects such as Molecular biology, which are connected to disciplines such as Cell biology and Exon.
His Lung cancer study combines topics from a wide range of disciplines, such as KRAS and Adenocarcinoma.
He most often published in these fields:
- Cancer research (30.18%)
- Tuberous sclerosis (26.14%)
- Genetics (25.79%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (30.18%)
- Internal medicine (22.98%)
- Oncology (14.56%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Internal medicine, Oncology, Tuberous sclerosis and TSC1.
His work deals with themes such as Cell growth, mTORC1, PI3K/AKT/mTOR pathway, Mutation and Renal cell carcinoma, which intersect with Cancer research.
His research in Internal medicine intersects with topics in Somatic cell, ARID1A and Medical genetics.
His Oncology research is mostly focused on the topic Lung cancer.
His Tuberous sclerosis research is under the purview of Pathology.
His TSC1 research is multidisciplinary, incorporating perspectives in Subependymal zone, Kidney Angiomyolipoma, Angiomyolipoma, Microphthalmia-associated transcription factor and TSC2.
Between 2017 and 2021, his most popular works were:
- The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (293 citations)
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology (289 citations)
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology (227 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
David J. Kwiatkowski mainly investigates Oncology, Internal medicine, Cancer research, Tuberous sclerosis and Lung cancer.
His work in the fields of Internal medicine, such as Urothelial carcinoma, intersects with other areas such as Hepatocyte Growth Factor Receptor.
The Cancer research study combines topics in areas such as Mutation, Cancer, Renal cell carcinoma and Chromophobe Renal Cell Carcinoma.
His research integrates issues of Autism, TSC2, TSC1 and Epilepsy in his study of Tuberous sclerosis.
TSC2 is a primary field of his research addressed under PI3K/AKT/mTOR pathway.
David J. Kwiatkowski has researched Lung cancer in several fields, including Fluorescence in situ hybridization, Guideline, Molecular pathology and KRAS.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
